Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

oleh: Roy Fleischmann, Patrick Durez, Yoshiya Tanaka, Eduardo Mysler, Louis Bessette, Yihan Li, In-Ho Song, Nasser Khan, Charles G Peterfy, Jerzy Swierkot, Xianwei Bu

Format: Article
Diterbitkan: BMJ Publishing Group 2022-02-01

Deskripsi

No description available for this item.